RMR Wealth Builders’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.52M Buy
5,958
+619
+12% +$468K 0.26% 60
2026
Q2
$3.33M Buy
5,339
+1,466
+38% +$998K 0.21% 72
2026
Q1
$2.99M Buy
3,873
+414
+12% +$317K 0.24% 65
2025
Q4
$2.67M Buy
3,459
+470
+16% +$319K 0.21% 62
2025
Q3
$1.68M Buy
2,989
+255
+9% +$144K 0.14% 85
2025
Q2
$1.44M Buy
2,734
+593
+28% +$331K 0.13% 94
2025
Q1
$1.36M Buy
+2,141
New +$1.47M 0.14% 92
2021
Q2
– Sell
-70
Closed -$33K – 576
2021
Q1
$33K Hold
70
– – 0.01% 436
2020
Q4
$34K Buy
+70
New +$37.8K 0.02% 297

Other funds holding REGN

RMR Wealth Builders's REGN Position: Q3 2026 in Review

RMR Wealth Builders increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q3 2026, buying an estimated $468K and bringing the position to 5,958 shares worth $4.52M. The position accounts for 0.26% of the portfolio, ranked #60.

RMR Wealth Builders first reported a position in REGN in Q4 2020 and has held it in 9 quarters since. 1,242 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • RMR Wealth Builders held 5,958 shares of Regeneron Pharmaceuticals worth $4.52M as of Q3 2026.
  • RMR Wealth Builders bought 619 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $468K.
  • Regeneron Pharmaceuticals made up 0.26% of RMR Wealth Builders's portfolio in Q3 2026, its #60 holding.
  • RMR Wealth Builders first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
  • 1,242 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on RMR Wealth Builders's 13F filing for Q3 2026, filed 22 Oct 2026.